van Ingen J - Search Results

1

Nationwide evaluation of treatment outcomes and survival of patients with non-tuberculous mycobacterial pulmonary disease.

Makek MJ, Glodic G, Sabol I, Zmak L, Samarzija M, Sola A, Marusic A, Marekovic I, Bulat LK, Corak L, Obrovac M, van Ingen J. Makek MJ, et al. Among authors: van ingen j. Int J Tuberc Lung Dis. 2024 Oct 1;28(10):482-487. doi: 10.5588/ijtld.24.0068. Int J Tuberc Lung Dis. 2024. PMID: 39334546

2

The rising incidence and clinical relevance of Mycobacterium malmoense: a review of the literature.

Hoefsloot W, Boeree MJ, van Ingen J, Bendien S, Magis C, de Lange W, Dekhuijzen PN, van Soolingen D. Hoefsloot W, et al. Among authors: van ingen j, van soolingen d. Int J Tuberc Lung Dis. 2008 Sep;12(9):987-93. Int J Tuberc Lung Dis. 2008. PMID: 18713494 Review.

3

Mycobacterial disease in patients with rheumatic disease.

van Ingen J, Boeree MJ, Dekhuijzen PN, van Soolingen D. van Ingen J, et al. Among authors: van soolingen d. Nat Clin Pract Rheumatol. 2008 Dec;4(12):649-56. doi: 10.1038/ncprheum0949. Nat Clin Pract Rheumatol. 2008. PMID: 19037226 Review.

4

Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands.

van Ingen J, Bendien SA, de Lange WC, Hoefsloot W, Dekhuijzen PN, Boeree MJ, van Soolingen D. van Ingen J, et al. Among authors: van soolingen d. Thorax. 2009 Jun;64(6):502-6. doi: 10.1136/thx.2008.110957. Epub 2009 Feb 12. Thorax. 2009. PMID: 19213773

5

Surgical treatment of non-tuberculous mycobacterial lung disease: strike in time.

van Ingen J, Verhagen AF, Dekhuijzen PN, van Soolingen D, Magis-Escurra C, Boeree MJ, de Lange WC. van Ingen J, et al. Among authors: van soolingen d. Int J Tuberc Lung Dis. 2010 Jan;14(1):99-105. Int J Tuberc Lung Dis. 2010. PMID: 20003702

6

In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands.

van Ingen J, van der Laan T, Dekhuijzen R, Boeree M, van Soolingen D. van Ingen J, et al. Among authors: van soolingen d, van der laan t. Int J Antimicrob Agents. 2010 Feb;35(2):169-73. doi: 10.1016/j.ijantimicag.2009.09.023. Epub 2009 Dec 16. Int J Antimicrob Agents. 2010. PMID: 20006470

7

The changing pattern of clinical Mycobacterium avium isolation in the Netherlands.

van Ingen J, Hoefsloot W, Dekhuijzen PN, Boeree MJ, van Soolingen D. van Ingen J, et al. Among authors: van soolingen d. Int J Tuberc Lung Dis. 2010 Sep;14(9):1176-80. Int J Tuberc Lung Dis. 2010. PMID: 20819265

8

Xpert MTB/RIF®, a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis.

Bowles EC, Freyée B, van Ingen J, Mulder B, Boeree MJ, van Soolingen D. Bowles EC, et al. Among authors: van ingen j, van soolingen d. Int J Tuberc Lung Dis. 2011 Jul;15(7):988-9. doi: 10.5588/ijtld.10.0574. Int J Tuberc Lung Dis. 2011. PMID: 21682978

9

Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge.

van Ingen J, Aarnoutse R, de Vries G, Boeree MJ, van Soolingen D. van Ingen J, et al. Among authors: van soolingen d. Int J Tuberc Lung Dis. 2011 Jul;15(7):990-2. doi: 10.5588/ijtld.10.0127. Int J Tuberc Lung Dis. 2011. PMID: 21682979

10

Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases.

Hoefsloot W, van Ingen J, Peters EJ, Magis-Escurra C, Dekhuijzen PN, Boeree MJ, van Soolingen D. Hoefsloot W, et al. Among authors: van ingen j, van soolingen d. Clin Microbiol Infect. 2013 May;19(5):432-7. doi: 10.1111/j.1469-0691.2012.03817.x. Epub 2012 Mar 22. Clin Microbiol Infect. 2013. PMID: 22439918 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters